Idiopathic Hypersomnia

The Idiopathic Hypersomnia pipeline: 3 tracked drugs, 1 approved for this indication.

Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Idiopathic Hypersomnia, so this list is not complete.

1 approved / phase 41 Phase 31 Phase 2/3

Compare the share prices of listed companies in Idiopathic Hypersomnia →

Market size not yet sourced. How markets are sized ↗

The Idiopathic Hypersomnia pipeline

← all assets